Search

everythinglearnresearchcommunity

for

Search:↓

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

TSH levels are similar across nonscarring alopecia types, with unclear racial differences.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Alopecia Areata Incognita causes sudden hair loss in young females but usually has a better outcome than other types.

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.

Early shedding of the inner root sheath in noninflamed hair follicles is a relatively specific sign of Central Centrifugal Cicatricial Alopecia.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Superficial cryotherapy is effective and safe for treating alopecia areata, especially eyebrow hair loss.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Reflectance confocal microscopy can help tell apart scarring from non-scarring hair loss.

A new method improves alopecia diagnosis using non-invasive steps.

Hair loss was found in 37.4% of surveyed rural high-school students in Eskisehir, Turkey, affecting their quality of life, especially in general health and mental well-being.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Most adults with alopecia have some quality of life impairment, mainly minimal to moderate, and are treated with minoxidil.

Janus kinase inhibitors help hair regrowth in kids with alopecia areata but need more safety research.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

Hair follicle counts and ratios are helpful in diagnosing hair loss types, but should be used with other specific features for accurate diagnosis.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.